Digital mental health technology: qualification and classification

AI Summary

This UK MHRA guidance document establishes the regulatory framework for manufacturers of Digital Mental Health Technologies (DMHTs). Rather than citing a specific company or inspection dates, the guidance applies broadly to any entity developing software or hardware intended for mental health support. The primary requirement is for manufacturers to evaluate their product based on intended purpose and functionality. If the device serves a medical purpose with complex functionality, it is classified as Software as a Medical Device (SaMD), necessitating compliance with rigorous safety and effectiveness standards. To avoid regulatory non-compliance, manufacturers must use this guidance to determine their device's risk level, ranging from Class I (low risk) to Class III (high risk). While Class I devices allow for self-certification, Class IIa, IIb, and III devices require independent assessment by approved or notified bodies. Required actions for manufacturers include identifying their product's specific characteristics, ensuring appropriate classification, and obtaining the necessary regulatory certification for the UK or European markets. This proactive approach ensures that AI algorithms, chatbots, and educational modules meet recognized safety standards before being made available to the public.